Elizabeth Buck

Insider Reports History

Entity
Individual
Location
C/O Black Diamond Therapeutics, Inc., One Main Street, 10 Th Floor, Cambridge, MA
Signature
/s/ Brent Hatzis-Schoch, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Elizabeth Buck:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Black Diamond Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Stock Option (Right to Buy) 200K Feb 14, 2024 Direct

Insider Reports Filed by Elizabeth Buck

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BDTX Black Diamond Therapeutics, Inc. Feb 14, 2024 1 $0 4 Feb 15, 2024 CHIEF SCIENTIFIC OFFICER
BDTX Black Diamond Therapeutics, Inc. Feb 13, 2023 1 $0 4 Feb 15, 2023 CHIEF SCIENTIFIC OFFICER
BDTX Black Diamond Therapeutics, Inc. Feb 15, 2022 1 $0 4 Feb 17, 2022 CHIEF SCIENTIFIC OFFICER
BDTX Black Diamond Therapeutics, Inc. Sep 15, 2021 0 $0 3 Sep 17, 2021 Chief Scientific Officer